Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Soumya Sachdeva
Posters-Accepted Abstracts: J Infect Dis Ther
Introduction: The ‘2nd- and 3rd-generation’ cephalosporins, presently used in the clinical setting; have been found to be effective
against beta lactamase producing bacteria. However resistance against these antibiotics has emerged in the form of ESBLs or
the extended spectrum beta lactamases.
Objective: Detection of Extended spectrum beta lactamases from archived isolates recovered from sterile fluids 2009-2010.
Methods: The study was performed at the Department of Microbiology, for a period of two months. A Total 50 archived
multi drug resistant gram negative bacillary isolates from various sterile fluid samples were randomly selected preserved from
October 2009 to June 2010; and were included in the study. These were first subcultured and then antibiotic sensitivity was
performed as per CLSI 2009. Disc diffusion test was applied to screen for antibiotic resistance. Screening for ESBL was carried
out using DDST (Double disc synergy test), and the results were further confirmed using E strip MIC method.
Results: The archived isolates included samples from male (%), female (%), adult (%) and pediatric (%) patients. The isolates
belonged to family Enterobacteriaceae-E.coli (n=16), Klebsiella (n=11), Acinetobacter (n=23). The maximum isolates showed
resistance to Piperacillin and piperacillin-tazobactam (n=37) followed by ceftazidime and ceftazidime-clavulanate (n=36), on
disc diffusion test. Total 72 % of the isolates reported to be positive for ESBL. The highest ESBL producers were recorded in E
.coli (87.5%), followed by Klebsiella (72.72%) and then by Acinetobacter (60.86%). Out of the total isolates, 10% were found to
be resistant to Imipenem and positive for MBL by the E strip method.
Conclusion: This study elucidates the wide prevalence of the ESBL producing bacteria which are now being recovered from
CNS infections and also that MBL resistance is the current budding threat to mankind.
Acknowledgement: This study was carried out as an ICMR STS 2010 project
Soumya Sachdeva has completed her MBBS (Bachelors of Medicine and Surgery) at the age of 24 years from Vardhman Mahavir Medical College and Safdarjung
Hospital, New Delhi, India. She is very passionate about medical research and has 5 publications in PubMed and 2 others in peer reviewed journals. She also is
the editor board of Journal of Young Medical Researchers, wikidoc.org and is also the Ambassdor for International Journal of Medical Students (IJMS).
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals